A study on the immune response induced by a DNA vaccine encoding Mtb۳۲C-HBHA antigen of Mycobacterium tuberculosis
- سال انتشار: 1396
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 20، شماره: 10
- کد COI اختصاصی: JR_IJBMS-20-10_007
- زبان مقاله: انگلیسی
- تعداد مشاهده: 222
نویسندگان
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical science, Tehran, Iran
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
Objective(s): Tuberculosis (TB) has still remained a global health issue. One third of the world's population is infected with tuberculosis and the current BCG vaccine has low efficiency; hence, it is necessary to develop a new vaccine against TB. The aim of the current study was to evaluate the efficiency of a novel DNA vaccine encoding Mtb۳۲C-HBHA antigen in inducing specific immune responses against Mycobacterium tuberculosis. Materials and Methods: A DNA plasmid vaccine expressing Mtb۳۲C-HBHA fusion protein was constructed and its ability in protein expression was examined by RT-PCR and Western blot methods. Female BALB/c mice were vaccinated with ۱۰۰ μg of purified recombinant vector in an attempt to assess its immunogenicity and protective efficacy. Further, the cytokines, IFN-γ, IL-۱۲, IL-۴, IL-۱۰, and TGF-β were assessed. Results: The levels of all the studied cytokines were significantly increased (P< ۰.۰۵) compared with the control group. IFN-γ production in the group receiving DNA vaccine plus BCG was increased compared with those receiving only DNA vaccine or BCG (P< ۰.۰۰۱). Conclusion: The immunogenicity of the new chimeric DNA vaccine was confirmed alone and in combination with BCG. Based on the results of the current study, the constructed DNA vaccine induced the expression of Mtb۳۲C-HBHA fusion protein efficiently in vitro. Furthermore, high levels of the specific cytokines were induced in mice. By using this DNA vaccine as a booster after BCG, higher amounts of IFN-γ will be produced.کلیدواژه ها
BCG, DNA, Mycobacterium tuberculosis, PCR, Plasmidاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.